Drug details

Imjudo (tremelimumab-actl injection)

type of Antineoplastics Monoclonal Antibody

Imjudo (tremelimumab-actl) is a cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blocking antibody indicated in combination with durvalumab, for the treatment of adult patients with unresectable hepatocellular carcinoma (uHCC).

This drug may have the following side effects:
  • hives,
  • difficulty breathing,
  • swelling of your face, lips, tongue, or throat,
  • loss of appetite,
  • itching,
  • dark urine,
  • rash,
  • diarrhea,
  • fever,
  • easy bruising,
  • unusual bleeding,
  • shortness of breath,
  • confusion,
  • chills,
  • tiredness,
  • dizziness,
  • constipation,
  • flu-like symptoms,
  • fainting,
  • weakness,
  • cough,
  • chest pain or pressure,
  • little or no urination,
  • increased thirst,
  • increased urination,
  • hoarseness,
  • mouth sores,
  • swelling in your feet or ankles,
  • flushing,
  • muscle cramps,
  • severe stomach pain,
  • irritability,
  • hair loss,
  • feeling cold,
  • shaking,
  • eye pain,
  • skin sores,
  • swollen lymph nodes,
  • severe nausea,
  • yellowing of your skin or eyes (jaundice),
  • severe headaches,
  • double vision,
  • increased sensitivity to light,
  • sleepiness,
  • increased appetite,
  • severe vomiting,
  • blurry vision,
  • decreased sex drive,
  • wheezing, and
  • excessive sweating,
  • fast or irregular heartbeats,
  • changes in mood or behavior,
  • abdominal pain (upper right side),
  • weight gain or loss,
  • back or neck pain
  • changes in your eyesight,
  • stiffness in your neck,
  • stool that is black or tarry,
  • problems with your memory,
  • skin that blisters or peels,
  • coordination or balance problems,
  • tingling or numbness of the arms or legs,
  • severe muscle pain,
  • blow red blood cells,
The following drugs are related to Imjudo, either as a replacement or used together:
  • Avastin (bevacizumab)
  • Balversa (erdafitinib tablets)
  • Cabometyx (cabozantinib tablets)
  • Lytgobi (futibatinib tablets)
  • Hepzato (melphalan for injection)
  • Keytruda (pembrolizumab for injection)
  • Lenvima (lenvatinib capsules)
  • Nexavar (sorafenib)
  • Stivarga (regorafenib tablets)